Company Quick10K Filing
MorphoSys AG
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 32 $811
20-F 2019-03-13 Annual: 2018-12-31

MorphoSys AG Financials

MOR Metrics, Comps, Filings

Annual | Quarterly

Business

20-F 1 d601506d20f.htm FORM 20-F Form 20-F Table of Contents

Copy History Germany 2834 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) Semmelweisstrasse 7 82152 Planegg Germany Telephone: +49 89-89927-0 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Securities registered or to be registered pursuant to Section 12(b) of the Act:


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Retrophin (RTRX) 879,436 97% -6.6 -22% 647,574 370,485 168,754 164,022 -141,649 -121,345 803,779
Kura Oncology (KURA) 876,215 -12.9 -23% 265,685 19,104 0 0 -59,987 -59,178 761,635
Axsome Therapeutics (AXSM) 871,650 -19.8 -77% 54,778 30,495 0 0 -42,282 -42,282 837,897
Zymeworks (ZYME) 865,043 0% -11.6 -13% 414,547 80,530 50,786 0 -52,196 -50,044 581,523
Principia Biopharma (PRNB) 856,298 0% 85.9 5% 192,339 21,661 79,861 0 9,488 9,489 814,658
Cara Therapeutics (CARA) 846,590 0% -8.3 -57% 149,641 50,096 20,185 0 -84,972 -85,252 710,961
Endo (ENDP) 837,647 45% 82.3 -6% 10,074,289 10,664,761 2,951,993 1,325,697 -589,691 90,738 7,464,876
Myovant Sciences (MYOV) 834,387 -2.6 -111% 250,873 171,306 0 0 -279,321 -267,680 706,465
Homology Medicines (FIXX) 827,381 0% -8.5 -25% 341,156 56,414 1,616 0 -83,919 -83,919 710,541
Vanda (VNDA) 818,501 22% 24.5 8% 372,483 75,789 208,949 46,994 28,445 31,454 771,214
MorphoSys AG (MOR) 810,636 0% 538,764 50,391 0 0 0 0 765,160
Macrogenics (MGNX) 802,830 0% -4.3 -41% 383,677 89,226 56,847 0 -155,457 -144,235 622,514
Rocket Pharmaceuticals (RCKT) 788,206 -7.1 -26% 308,720 60,216 0 0 -81,539 -75,184 530,406
Rhythm Pharmaceuticals (RYTM) 779,644 -5.1 -55% 210,888 29,421 0 0 -114,963 -114,191 584,477
Mallinckrodt (MNK) 759,543 37% -2.5 -34% 10,221,700 7,146,500 3,775,800 1,401,100 -3,442,900 -2,141,200 5,370,543
Omeros (OMER) 758,603 99% -9.5 -113% 89,760 220,034 75,157 74,778 -101,804 -79,564 754,617
Y-mAbs Therapeutics (YMAB) 756,364 -10.7 -47% 126,040 17,658 0 0 -59,456 -59,403 636,201
Kiniksa Pharmaceuticals (KNSA) 755,030 -2.7 -55% 308,137 32,940 0 0 -169,998 -170,154 467,583
Arvinas (ARVN) 750,259 0% -12.3 -35% 172,046 55,541 14,848 0 -61,045 -60,182 740,994
TG Therapeutics (TGTX) 745,044 0% -8.3 -81% 106,585 93,380 266 0 -86,755 -85,932 715,083

Balance Sheet ($'000)2018-12-31
Cash45,476
Accounts Receivable
Inventory
PP&E
Assets538,764
Accounts Payable
Long-Term Debt
Liabilities50,391
Stockholders' Equity
Income Statement ($'000)2018-12-31
Revenue76,443
Cost of Revenue1,797
Gross Profit74,646
R&D106,397
SG&A28,310
Tax
Net Income-56,172
Cash Flow ($'000)2018-12-31
Cash Operating
Cash Investing
Cash Financing